My Companies
Notification
Account
Log Out
Login
Received 9 USFDA No DMF Deficiency letters for Metformin HCl in July-August 2026 plus letters for Paroxetine and Diphenhydramine HCl. Commercialised Rs10 crore annual Metformin DC business in Saudi Arabia and customer-won Rs15 crore per annum two-year Mexico tender. Validating Quetiapine, Sitagliptin, Empagliflozin for filing next quarter.
Wanbury Secures Rivaroxaban EDQM Approval And Two USFDA DMF Clearances
Wanbury Tanuku Facility Receives USFDA Form 483 With Six Observations
Wanbury Board Approves Early Redemption of ₹180 Crore NCDs
Wanbury Trustee Releases 24.39% Pledge on Expert Chemicals Holding